Corticosteroids exposure is a common risk factor for invasive fungal infections. Systemic corticosteroid therapy treats several medical conditions, including rejection in solid organ transplant recipients, malignancy, and autoimmune or inflammatory diseases. Corticosteroid exposure is a well-known risk factor for developing PJP. Still, it remains unclear how prior corticosteroid exposure influences the presentation, severity, and mortality of opportunistic fungal infections. The investigators aim to prospectively characterize the corticosteroid use as a dose response to inform risk of invasive fungal infections.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
PJP
Timeframe: 3-6 months after first corticosteroid use
Cryptococcosis
Timeframe: 3-6 months after first corticosteroid use
Aspergillosis
Timeframe: 3-6 months after first corticosteroid use
Candidiasis
Timeframe: 3-6 months after first corticosteroid use